Skip to content

Author

Xuehong Zheng

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Enzyme-enhanced albumin-stabilized nanopolymers for cascade catalysis-driven ferroptosis-immunotherapy.

Ferroptosis, an iron-dependent form of programmed cell death, holds significant promise for cancer therapy due to its unique redox-driven mechanism and immunogenic potential. However, its therapeutic efficacy is often compromised by inadequate catalytic kinetics and an unfavorable tumor microenvironment. Here, we develop a multifunctional nanocatalyst (BCuP@G) based on albumin-stabilized polypyrrole doped with multivalent Cu ions and conjugated with glucose oxidase (GOx) to enable enzyme-enhanced cascade catalysis for ferroptosis-immunotherapy. The embedded Cu+/Cu2+ redox centers catalyze glutathione depletion and ·OH generation, while GOx continuously supplies H2O2 through glucose oxidation. Upon NIR-II laser irradiation, the photothermal effect further accelerates both enzymatic and catalytic kinetics, triggering excessive redox imbalance, lipid peroxidation, and synergistic ferroptosis-apoptosis. Moreover, BCuP@G demonstrates effective tumor accumulation and potent antitumor efficacy, particularly in combination with anti-PD-1 therapy, which promotes tumor-associated macrophage repolarization and T cell infiltration. This study presents a robust cascade-catalytic nanoplatform that integrates redox modulation and immune activation for advanced ferroptosis-enhanced cancer immunotherapy.

Peng Yu, Shuchun Yu, Xiaoping Yin et al. · 0 citations